MANGALAM — Mangalam Drugs and Organics Share News
0.000.00%
Last trade - 00:00- IN₹453.48m
- IN₹1.47bn
- IN₹2.32bn
Brief: Mangalam Drugs And Organics - Gets Interim Relief From Appellate Tribunal Over SEBI Order
Brief: India's Mangalam Drugs And Organics Sept-Quarter Net PAT Rises
Brief: India's Mangalam Drugs And Organics Posts March-Qtr Net PAT
Brief: Mangalam Drugs And Organics Gets Certificate Of Suitability For Hydroxychloroquine Sulphate
Brief: India's Mangalam Drugs & Organics Gears Up Production Of HCQS, CQP APIs
Brief: India's Mangalam Drugs And Organics Reports Dec Qtr Net Profit After Tax
Brief: Mangalam Drugs And Organics Jun-Qtr profit Rises
Brief: India's Mangalam Drugs And Organics Posts Dec Qtr Net Loss
Brief: Mangalam Drugs And Organics Gets WHO Pre-Qualification Approval For Co's Unit-1
Brief: India's Mangalam Drugs And Organics Sept-Qtr Net Profit Falls
Brief: India's Mangalam Drugs And Organics Receives Final Approval From WHO For Efavirenz
Brief: India's Mangalam Drugs And Organics June-Qtr NPAT 6.7 Mln Rupees
Brief: India's Mangalam Drugs & Organics March Quarter Profit Falls
Brief: India's Mangalam Drugs & Organics Dec Qtr Profit Falls
Brief: Mangalam Drugs And Organics Declares Interim Dividend Of 0.50 Rupees Per Share
Brief: India's Mangalam Drugs and Organics Sept-qtr profit rises
Brief: India's Mangalam Drugs & Organics gets final nod from WHO for emtricitabine
Brief: India's Mangalam Drugs and Organics June-qtr profit falls
Brief: India's Mangalam Drugs and Organics March-qtr profit rises